MedPath

A long-term extension study of HP-5070 in patients with primary hyperhidrosis

Phase 3
Conditions
Primary local hyperhidrosis
Registration Number
JPRN-jRCT2031200143
Lead Sponsor
Customer Service Office
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients who continued into the extension
- Japanese patients with primary local hyperhidrosis who completed the prior study
- Patients wishing to continue to receive HP-5070 after participating in the prior study

New patients
- Japanese patients aged 12 years or older
- Patients with a diagnosis of primary local hyperhidrosis
- Patients with involvement of palmar sites

Exclusion Criteria

Patients who continued into the extension
- Patients with a resting pulse rate of less than 45 beats per minute or more than 90 beats per minute measured during the pre-observation period of the prior study
- Patients with a QTcF of 450 msec or more on a 12-lead ECG measured during the pre-observation period of the prior study
- Patients with abnormal waveforms on a 12-lead ECG measured during the pre-observation period of the prior study

New patients
- Patients with secondary hyperhidrosis
- Patients with heavy sweating due to climacteric disturbance
- Patients who have undergone surgery for hyperhidrosis (sympathectomy, nerve block, laser surgery, etc.)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adverse events
Secondary Outcome Measures
NameTimeMethod
The proportion of responders with the defined volume of sweat
© Copyright 2025. All Rights Reserved by MedPath